Latest filing published 16 Dec 2025 for Traws Pharma, Inc..
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Werner Cautreels across 2 companies, led by Traws Pharma, Inc. and Cartesian Therapeutics, Inc. We count 4 filings; the first trade dates from 13 November 2017 and the latest from 12 December 2025.
On the market, this insider has only ever bought: 1 purchase, €160k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 2 share grants and 1 option exercise.
On 16 December 2025 came the latest disclosure, a share grant in Traws Pharma, Inc. The clock since the last published purchase (14 November 2017) now reads 3,265 days. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations